SONOMA PHARMACEUTICALS, INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$5.09 million for the 12-month period ending 2022-03-31, per its 10-K filed 2022-07-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2022-07-13
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$2.94M.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-12-31 was -$944.00K.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-09-30 was -$100.00K, a 166.23% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-06-30 was -$1.10M.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$5.09M.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was -$4.62M.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$3.57M.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2018 was -$14.33M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2022-03-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-13 | -$3.89M derived: sum of 2 quarters · filed 2022-07-13 | -$3.99M derived: sum of 3 quarters · filed 2022-07-13 | -$5.09M 10-K · filed 2022-07-13 | ||
| 2021-12-31 | -$944.00K 10-Q · filed 2022-02-11 | -$1.04M derived: sum of 2 quarters · filed 2022-02-11 | -$2.14M 10-Q · filed 2022-02-11 | -$5.57M derived: sum of 4 quarters · filed 2022-07-13 | ||
| 2021-09-30 | -$100.00K 10-Q · filed 2021-11-15 | -$1.20M 10-Q · filed 2021-11-15 | -$4.63M derived: sum of 3 quarters · filed 2022-07-13 | -$5.26M derived: sum of 4 quarters · filed 2022-07-13 | ||
| 2021-06-30 | -$1.10M 10-Q · filed 2021-08-16 | -$4.53M derived: sum of 2 quarters · filed 2022-07-13 | -$5.16M derived: sum of 3 quarters · filed 2022-07-13 | -$5.00M derived: sum of 4 quarters · filed 2022-07-13 | ||
| 2021-03-31 | -$3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-13 | -$4.06M derived: sum of 2 quarters · filed 2022-07-13 | -$3.91M derived: sum of 3 quarters · filed 2022-07-13 | -$4.62M 10-K · filed 2022-07-13 | ||
| 2020-12-31 | -$626.00K 10-Q · filed 2022-02-11 | -$475.00K derived: sum of 2 quarters · filed 2022-02-11 | -$1.18M 10-Q · filed 2022-02-11 | -$2.93M derived: sum of 4 quarters · filed 2022-02-11 | ||
| 2020-09-30 | $151.00K 10-Q · filed 2021-11-15 | -$557.00K 10-Q · filed 2021-11-15 | -$2.31M derived: sum of 3 quarters · filed 2021-11-15 | -$3.52M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | -$709.00K 10-Q · filed 2021-08-16 | $39.00K 10-Q · filed 2020-08-14 | -$2.46M derived: sum of 2 quarters · filed 2021-08-16 | -$3.67M derived: sum of 3 quarters · filed 2021-08-16 | -$4.96M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-14 | -$2.96M derived: sum of 2 quarters · filed 2021-07-14 | -$4.25M derived: sum of 3 quarters · filed 2021-07-14 | -$3.57M 10-K · filed 2021-07-14 | ||
| 2019-12-31 | -$1.21M 10-Q · filed 2021-02-16 | -$2.50M derived: sum of 2 quarters · filed 2021-02-16 | -$1.82M 10-Q · filed 2021-02-16 | |||
| 2019-09-30 | -$1.29M 10-Q · filed 2020-11-20 | -$614.00K 10-Q · filed 2020-11-20 | ||||
| 2019-06-30 | $674.00K 10-Q/A · filed 2020-11-17 | $531.00K 10-Q · filed 2020-08-14 | ||||
| 2018-03-31 | -$4.76M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | -$7.95M derived: sum of 2 quarters · filed 2018-06-26 | -$10.82M derived: sum of 3 quarters · filed 2018-06-26 | -$14.33M 10-K · filed 2018-06-26 | ||
| 2017-12-31 | -$3.19M 10-Q · filed 2018-02-14 | -$6.06M derived: sum of 2 quarters · filed 2018-02-14 | -$9.56M 10-Q · filed 2018-02-14 | -$8.45M derived: sum of 4 quarters · filed 2018-06-26 | ||
| 2017-09-30 | -$2.87M 10-Q · filed 2017-11-14 | -$6.38M 10-Q · filed 2017-11-14 | -$5.27M derived: sum of 3 quarters · filed 2018-06-26 | -$8.54M derived: sum of 4 quarters · filed 2018-06-26 | ||
| 2017-06-30 | -$3.51M 10-Q · filed 2017-08-08 | -$2.40M derived: sum of 2 quarters · filed 2018-06-26 | -$5.67M derived: sum of 3 quarters · filed 2018-06-26 | -$8.67M derived: sum of 4 quarters · filed 2018-06-26 | ||
| 2017-03-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | -$2.17M derived: sum of 2 quarters · filed 2018-06-26 | -$5.16M derived: sum of 3 quarters · filed 2018-06-26 | -$8.67M 10-K · filed 2018-06-26 | ||
| 2016-12-31 | -$3.28M 10-Q · filed 2018-02-14 | $763.00K 10-Q · filed 2017-02-17 | -$6.27M derived: sum of 2 quarters · filed 2018-02-14 | -$9.78M 10-Q · filed 2018-02-14 | -$5.74M 10-Q · filed 2017-02-17 | -$13.44M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | -$3.00M 10-Q · filed 2017-11-14 | -$6.50M 10-Q · filed 2017-11-14 | -$10.17M derived: sum of 3 quarters · filed 2017-11-14 | -$14.38M derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | -$3.51M 10-Q · filed 2017-08-08 | -$7.17M derived: sum of 2 quarters · filed 2017-08-08 | -$11.39M derived: sum of 3 quarters · filed 2017-08-08 | |||
| 2016-03-31 | -$3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | -$7.88M derived: sum of 2 quarters · filed 2017-06-28 | -$14.72M 10-K · filed 2017-06-28 | |||
| 2015-12-31 | -$4.21M 10-Q · filed 2017-02-17 | -$11.06M 10-Q · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |